Molecular imaging of photodynamic therapy

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 6097, Issue , 2006, Pages

  Chang, Sung K ^a   Errabelli, Divya ^a   Rizvi, Imran ^a   Solban, Nicolas ^a   O'Riordan, Katherine ^a   Hasan, Tayyaba ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Molecular imaging; Optical imaging; Photodynamic therapy

Indexed keywords

FLUORESCENCE MICROSCOPES; MOLECULAR IMAGING; OPTICAL IMAGING;

MEDICAL IMAGING; OPTICAL RESOLVING POWER; PHARMACOKINETICS; PHOTODETECTORS; PHOTOSENSITIZERS;

PHOTODYNAMIC THERAPY;

EID: 33646167837     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.649844     Document Type: Conference Paper

References (23)

1. Momma T, Hamblin MR, Wu HC, Hasan T. Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: Local control and distant metastasis. Cancer Res. 1998 Dec 1;58(23):5425-31.
2. Windahl T, Andersson SO, Lofgren L. Photodynamic therapy of localised prostatic cancer. Lancet. 1990 Nov 3;336(8723):1139.
3. Nathan TR, Whitelaw DE, Chang SC, Lees WR, Ripley PM, Payne H, et al. Photodynamic therapy for prostate cancer recurrence after radiotherapy: A phase 1 study. J Urol. 2002 Oct; 168(4 Pt 1):1427-32.
4. Noodt BB, Berg K, Stokke T, Peng Q, Nesland JM. Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light. Br J Cancer. 1999;79(1):72-81.
5. Kessel D, Luguya R, Vicente MG. Localization and photodynamic efficacy of two cationic porphyrins varying in charge distributions. Photochem Photobiol. 2003 Nov;78(5):431-5.
6. Ortel B, Sharlin D, O'Donnell D, Sinha AK, Maytin EV, Hasan T. Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells. Br J Cancer. 2002 Nov 18;87(11):1321-7.
7. Henderson BW, Dougherty TJ. How does photodynamic therapy work?. Photochem Photobiol. 1992;55(1Division of Radiation Biology, Roswell Park Cancer Institute, Buffalo, NY. Using Smart Source Parsing Jan): 145-157.
8. Fingar VH, Kik PK, Haydon PS, Cerrito PB, Tseng M, Abang E, et al. Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD). Br J Cancer. 1999 Apr;79(11-12): 1702-8.
9. Fingar VH, Taber SW, Haydon PS, Harrison LT, Kempf SJ, Wieman TJ. Vascular damage after photodynamic therapy of solid tumors: A view and comparison of effect in pre-clinical and clinical models at the university of louisville. In Vivo. 2000 Jan-Feb;14(1):93-100.
10. Chen Q, Chen H, Hetzel FW. Tumor oxygenation changes post-photodynamic therapy. Photochem Photobiol. 1996 Jan;63(1):128-31.
11. Ferrara N. Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev. 2004 Aug;25(4):581-611.
12. Balbay MD, Pettaway CA, Kuniyasu H, Inoue K, Ramirez E, Li E, et al. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor. Clin Cancer Res. 1999 Apr;5(4):783-9.
13. Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, Salloum RM, et al. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res. 1999 Jul 15;59(14):3374-8.
14. Uehara M, Inokuchi T, Sano K, ZuoLin W. Expression of vascular endothelial growth factor in mouse tumours subjected to photodynamic therapy. Eur J Cancer. 2001 Nov;37(16):2111-5.
15. Jiang F, Zhang ZG, Katakowski M, Robin AM, Faber M, Zhang F, et al. Angiogenesis induced by photodynamic therapy in normal rat brains. Photochem Photobiol. 2004 Jun;79(6):494-8.
16. Momma T, Hamblin MR, Wu HC, Hasan T. Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: Local control and distant metastasis. Cancer Res. 1998 Dec 1;58(23):5425-31.
17. Camphausen K, Moses MA, Beecken WD, Khan MK, Folkman J, O'Reilly MS. Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res. 2001 Mar 1;61(5):2207-11.
18. Kozin SV, Boucher Y, Hicklin DJ, Bohlen P, Jain RK, Suit HD. Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts. Cancer Res. 2001 Jan 1;61(1):39-44.
19. Ferrario A, von Tiehl KF, Rucker N, Schwarz MA, Gill PS, Gomer CJ. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res. 2000 Aug 1;60(15):4066-9.
20. Jayson GC, Zweit J, Jackson A, Mulatero C, Julyan P, Ranson M, et al. Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: Implications for trial design of antiangiogenic antibodies. J Natl Cancer Inst. 2002 Oct2;94(19):1484-93.
21. Monsky WL, Fukumura D, Gohongi T, Ancukiewcz M, Weich HA, Torchilin VP, et al. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res. 1999 Aug 15;59(16):4129-35.
22. Liu XH, Kirschenbaum A, Yao S, Stearns ME, Holland JF, Claffey K, et al. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis. 1999;17(8):687-94.
23. Yuan F, Leunig M, Berk DA, Jain RK. Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. Microvasc Res. 1993 May;45(3):269-89.